Prevalence of the metabolic syndrome in a bulgarian female population referred for bone density testing

Obesity Research

Volumn 13, Issue 9, 2005, Pages 1505-1509

  Boyanov, Mihail A ^a   Chrislov, V G ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Diabetes; Dyslipidemia; Hypertension; Metabolic syndrome; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; BULGARIA; CAUCASIAN; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINISM; HYPERTENSION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE;

ADULT; AGED; BULGARIA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERINSULINISM; HYPERTENSION; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE;

EID: 33644664258     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.182     Document Type: Article

References (20)

1. Reaven G. Role of insulin resistance in human disease. Diabates. 1988;37:1595-607.
2. DeFronzo R, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible l'or NIDDM. obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Cure. 1991;14:173-94.
3. Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab. 2003;29:6519-27.
4. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
5. Balkau B, Vernay M, Mhamdi L, et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: The French D.E.S.I.R. study. Diabetes Metab. 2003;29:526-32.
6. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28:364-76.
7. Boulogne A, Vantyghem MC. Donnees epidemiologiques et criteres de depistage du syndrome metabolique. Presse Med. 2004;33:662-5.
8. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-7.
9. National Statistical Institute. Health care data. National Statistical Repart 2003. Sofia. Bulgaria; National Statistical Institute Publishing Center, 2003.
10. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-4.
11. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285-92.
12. Shimamoto K. Epidemiologic study on metabolic syndrome: comparison between Japan and western countries. Nippon Rinsho. 2004;62:1053-8.
13. Santos AC, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol. 2004;23:45-52.
14. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7.
15. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol. 2004;33:328-36.
16. Kahn HS, Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr. 2003;78:928-34.
17. Lakka TA, Laaksonen DE, Lakka HM, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc. 2003;35:1279-86.
18. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404-11.
19. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-81.
20. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care. 2003;26:1635.